InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

- Current share price for RAP : $0.026

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10 Change of Director's Interest Notice - Chris Ntoumenopoulos 16 Mar 2021 9:56AM $0.072 $0.026 fallen by 63.89%
$10 Change of Director's Interest Notice - Tony Keating 16 Mar 2021 9:52AM $0.072 $0.026 fallen by 63.89%
$10 Change of Director's Interest Notice - Roger Aston 16 Mar 2021 9:51AM $0.072 $0.026 fallen by 63.89%
$10 Change in substantial holding 16 Mar 2021 8:20AM $0.072 $0.026 fallen by 63.89%
$10 Change in substantial holding 16 Mar 2021 8:20AM $0.072 $0.026 fallen by 63.89%
$10 Section 708A Notice and Appendix 2A 12 Mar 2021 5:06PM $0.068 $0.026 fallen by 61.76%
$10 S&P DJI Announces March 2021 Quarterly Rebalance 12 Mar 2021 5:02PM $0.068 $0.026 fallen by 61.76%
$10 ResApp grants SDK licence to AstraZeneca for asthma program 12 Mar 2021 9:01AM $0.058 $0.026 fallen by 55.17%
$10 Clinical study to develop COVID-19 screening test 11 Mar 2021 10:07AM $0.057 $0.026 fallen by 54.39%
$10 Medgate commences European ResAppDx trial 4 Mar 2021 9:13AM $0.059 $0.026 fallen by 55.93%
$10 Proposed issue of Securities - RAP 2 Mar 2021 9:48AM $0.057 $0.026 fallen by 54.39%
$10 CE Mark achieved for wearable device 2 Mar 2021 9:37AM $0.057 $0.026 fallen by 54.39%
$10 Update on Licencing Agreement with WMA 26 Feb 2021 9:14AM $0.057 $0.026 fallen by 54.39%
$10 Resignation of Joint Company Secretary 25 Feb 2021 7:44PM n/a $0.026 n/a
$10 Appendix 4D and Half Year Financial Report 24 Feb 2021 9:20AM $0.059 $0.026 fallen by 55.93%
$10 Pre-Submission package lodged with the US FDA 10 Feb 2021 8:58AM $0.067 $0.026 fallen by 61.19%
$10 ResApp receives $801,738 R&D tax incentive refund and grant 4 Feb 2021 9:09AM $0.068 $0.026 fallen by 61.76%
$10 ResApp strengthens patent position in Europe 2 Feb 2021 8:59AM $0.066 $0.026 fallen by 60.61%
$10 Quarterly Activities Report and Appendix 4C 29 Jan 2021 9:17AM $0.078 $0.026 fallen by 66.67%
$10 Quarterly Results and Investor Conference Call Notification 28 Jan 2021 8:37AM $0.079 $0.026 fallen by 67.09%
$10 Appendix 3G 12 Jan 2021 6:13PM $0.076 $0.026 fallen by 65.79%
$10 ResApp appoints VP, Commercial to progress growth strategy 11 Jan 2021 9:26AM $0.079 $0.026 fallen by 67.09%
$10 SleepCheck Launched on Select Android Devices 29 Dec 2020 9:14AM $0.080 $0.026 fallen by 67.50%
$10 ResApp Terminates MOU with RB 23 Dec 2020 9:25AM $0.083 $0.026 fallen by 68.67%
$10 Software updates for ResAppDx to underpin growth 22 Dec 2020 9:32AM $0.083 $0.026 fallen by 68.67%

176 - 200 of 570 results

Page 8 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.